Top Story

Combination of trastuzumab, XELOX shows promise for advanced gastric cancer

February 27, 2015

The addition of trastuzumab to the standard first-line regimen of capecitabine plus oxaliplatin created a highly effective and well-tolerated combination for the treatment of advanced gastric cancer, according to results of a phase 2 study.

Advancements in the understanding of gastric cancer biology have led to targeted therapies focused on HER-2.

In the Journals

Smoking increases mortality risk in patients with colorectal cancer

February 27, 2015
Cigarette smoking is associated with a higher mortality rate among patients with invasive, nonmetastatic colorectal cancer, according to results of a study led by…
In the Journals

Statin use may reduce risk for liver cancer

February 26, 2015
The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data. “The…
In the Journals

Tumor location in colorectal cancer may predict survival

February 26, 2015
The location of tumors in the colon may be an important prognostic factor for patients with treatment-naive metastatic colorectal cancer, according to study…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
In the Journals

Combination of trastuzumab, XELOX shows promise for advanced gastric cancer

February 27, 2015
The addition of trastuzumab to the standard first-line regimen of capecitabine plus oxaliplatin created a highly effective and well-tolerated…
In the Journals

Smoking increases mortality risk in patients with colorectal cancer

February 27, 2015
Cigarette smoking is associated with a higher mortality rate among patients with invasive, nonmetastatic colorectal cancer, according to results of a…
In the Journals

Statin use may reduce risk for liver cancer

February 26, 2015
The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published…
In the Journals

Tumor location in colorectal cancer may predict survival

February 26, 2015
The location of tumors in the colon may be an important prognostic factor for patients with treatment-naive metastatic colorectal cancer, according…
In the Journals

Nexavar, TACE well tolerated in elderly patients with HCC

February 25, 2015
Nexavar and transarterial chemoembolization combination therapy for advanced hepatocellular carcinoma was well tolerated by elderly patients…

HEAT Study: ThermoDox increased OS in patients with HCC

February 23, 2015
Updated results from the HEAT Study indicated an increased overall survival rate among patients with primary liver cancer when treated with ThermoDox…
Older donor age, nonlocal distribution potentially increase HCC recurrence after liver transplant In the Journals

Older donor age, nonlocal distribution potentially increase HCC recurrence after liver transplant

February 18, 2015
Liver transplant recipients were at increased risk for hepatocellular carcinoma recurrence if they received a liver from a donor aged at least 60…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to Reolysin for pancreatic cancer

February 17, 2015
The FDA granted orphan drug status to pelareorep for the treatment of pancreatic cancer, the drug’s manufacturer announced today. Pelareorep…
Rebecca Richards-Kortum, MD In the Journals

Analysis of microendoscopic images helps diagnose esophageal squamous neoplasia

February 17, 2015
High-resolution microendoscopy with quantitative image analysis was useful for identifying esophageal squamous neoplasia with high sensitivity and…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to entrectinib for colorectal cancer

February 17, 2015
The FDA has granted orphan drug designation to entrectinib for the treatment of several molecularly-defined subtypes of colorectal cancer, according…
More Headlines »
morganatic-roan